Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia

被引：5
|
作者：
Hallner, Alexander [1 ]
Aurelius, Johan [1 ]
Thoren, Fredrik Bergh [1 ]
Sander, Frida Ewald [1 ]
Brune, Mats [1 ]
Hellstrand, Kristoffer [1 ]
Martner, Anna [1 ]
机构：
[1] Univ Gothenburg, Sahlgrenska Canc Ctr, S-40530 Gothenburg, Sweden
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2015年 / 94卷 / 03期
关键词：
D O I：
10.1111/ejh.12454
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：279 / 280
页数：2
相关论文
共 50 条
  • [31] Diabetes mellitus induced by low-dose interleukin-2
    Soni, N
    Meropol, NJ
    Porter, M
    Caligiuri, MA
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1996, 43 (01) : 59 - 62
  • [32] Low-Dose Interleukin-2 for Refractory Autoimmune Hepatitis
    Lim, Tiong Y.
    Martinez-Llordella, Marc
    Kodela, Elisavet
    Gray, Elisabeth
    Heneghan, Michael A.
    Sanchez-Fueyo, Alberto
    [J]. HEPATOLOGY, 2018, 68 (04) : 1649 - 1652
  • [33] Low-dose interleukin-2 for systemic lupus erythematosus?
    Wallace, Daniel J.
    [J]. LANCET RHEUMATOLOGY, 2019, 1 (01): : E7 - E8
  • [34] Immunotherapy with low-dose interleukin-2 in patients with myelodysplastic syndromes RAEB and RAEB-T.
    Faber, F
    Indrak, K
    Neuwirtova, R
    Mocikova, K
    Kuvikova, A
    Jarosova, M
    Pikalova, Z
    [J]. BLOOD, 1997, 90 (10) : 4036 - 4036
  • [35] Immunotherapy with low-dose interleukin-2: Rationale for prevention of immune-deficiency-associated cancer
    Khatri, VP
    Baiocchi, RA
    Bernstein, ZP
    Caligiuri, MA
    [J]. CANCER JOURNAL, 1997, 3 : S128 - S136
  • [36] Alternating chemo-immunotherapy with temozolomide and low-dose interleukin-2 in patients with metastatic melanoma
    Masucci, Giuseppe Valentino
    Mansson-Brahme, Eva
    Ragnarsson-Olding, Boel
    Nilsson, Bo
    Wagenius, Gunnar
    Hansson, Johan
    [J]. MELANOMA RESEARCH, 2006, 16 (04) : 357 - 363
  • [37] High-dose interleukin-2 may not be superior to low-dose interleukin-2 plus interferon - Reply
    McDermott, DF
    Regan, MM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6268 - 6269
  • [38] SCHEDULING OF ULTRA-LOW DOSE INTERLEUKIN-2 IN IMMUNOTHERAPY
    LINDEMANN, A
    MERTELSMANN, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1993, 29A (16) : 2336 - 2336
  • [39] LOW-DOSE CYTARABINE IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA
    BERIS, P
    RIEDER, A
    ANDREY, C
    HELG, C
    CHAPUIS, B
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1984, 114 (48) : 1763 - 1766
  • [40] EFFECTIVENESS AND TOLERABILITY OF LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTRAVENOUS INTERLEUKIN-2 DISSEMINATED MELANOMA
    MITCHELL, MS
    KEMPF, RA
    HAREL, W
    SHAU, H
    BOSWELL, WD
    LIND, S
    BRADLEY, EC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) : 409 - 424
12345